These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19995182)

  • 1. Candida albicans biofilm formation and its clinical consequences.
    Uppuluri P; Pierce CG; López-Ribot JL
    Future Microbiol; 2009 Dec; 4(10):1235-7. PubMed ID: 19995182
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.
    Kuhn DM; Chandra J; Mukherjee PK; Ghannoum MA
    Infect Immun; 2002 Feb; 70(2):878-88. PubMed ID: 11796623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans biofilm growth and dispersal: contributions to pathogenesis.
    Wall G; Montelongo-Jauregui D; Vidal Bonifacio B; Lopez-Ribot JL; Uppuluri P
    Curr Opin Microbiol; 2019 Dec; 52():1-6. PubMed ID: 31085405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilm of Candida albicans: formation, regulation and resistance.
    Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
    J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host responses to Candida albicans. A review.
    Zdanavičienė E; Sakalauskienė J; Gleiznys A; Gleiznys D; Žilinskas J
    Stomatologija; 2017; 19(4):109-123. PubMed ID: 29806649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to build a biofilm: a fungal perspective.
    Blankenship JR; Mitchell AP
    Curr Opin Microbiol; 2006 Dec; 9(6):588-94. PubMed ID: 17055772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida biofilm: a well-designed protected environment.
    Mukherjee PK; Zhou G; Munyon R; Ghannoum MA
    Med Mycol; 2005 May; 43(3):191-208. PubMed ID: 16010846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
    Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
    Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans.
    Berman J
    Curr Biol; 2012 Aug; 22(16):R620-2. PubMed ID: 22917504
    [No Abstract]   [Full Text] [Related]  

  • 10. Temporal Profile of Biofilm Formation, Gene Expression and Virulence Analysis in Candida albicans Strains.
    de Barros PP; Rossoni RD; De Camargo Ribeiro F; Junqueira JC; Jorge AO
    Mycopathologia; 2017 Apr; 182(3-4):285-295. PubMed ID: 27830437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of RPS41 in Biofilm Formation, Virulence, and Hydrogen Peroxide Sensitivity in Candida albicans.
    Lu H; Xiong J; Shang Q; Jiang Y; Cao Y
    Curr Microbiol; 2016 Jun; 72(6):783-7. PubMed ID: 26952720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic factors in Candida biofilm-related infectious diseases.
    Hirota K; Yumoto H; Sapaar B; Matsuo T; Ichikawa T; Miyake Y
    J Appl Microbiol; 2017 Feb; 122(2):321-330. PubMed ID: 27770500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.
    Villar-Vidal M; Marcos-Arias C; Eraso E; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):660-5. PubMed ID: 21899928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized candidal biofilm microtiter assay.
    Krom BP; Cohen JB; McElhaney Feser GE; Cihlar RL
    J Microbiol Methods; 2007 Feb; 68(2):421-3. PubMed ID: 17005276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dispersion as an important step in the Candida albicans biofilm developmental cycle.
    Uppuluri P; Chaturvedi AK; Srinivasan A; Banerjee M; Ramasubramaniam AK; Köhler JR; Kadosh D; Lopez-Ribot JL
    PLoS Pathog; 2010 Mar; 6(3):e1000828. PubMed ID: 20360962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and Optimizations of Candida albicans
    Lohse MB; Gulati M; Valle Arevalo A; Fishburn A; Johnson AD; Nobile CJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289028
    [No Abstract]   [Full Text] [Related]  

  • 18. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.
    Al-Fattani MA; Douglas LJ
    J Med Microbiol; 2006 Aug; 55(Pt 8):999-1008. PubMed ID: 16849719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative Abundances of Candida albicans and Candida glabrata in
    Olson ML; Jayaraman A; Kao KC
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.